Biogaia has signed a long-term agreement with Aché for the exclusive rights to sell Biogaia’s probiotic drops and tablets in Brazil.
According to Biogaia the products will be co-branded with expected launch in mid-2014.
”We are pleased to engage in an enduring collaboration with BioGaia, enabling the launch of relevant products in the Brazilian market. The well-studied probiotic products will address important unmet medical needs, especially in the child health segment, and combined with the recognised country-wide footprint and leadership of Aché, it will rapidly become an important therapeutic alternative adopted by the physicians in Brazil”, said Celso Sustovich, Executive Director of Aché.
“Our focus on the BRIC-countries is giving results. Brazil is a very important market and both our drops and tablets are already registered there after a long and difficult process. We are convinced that Brazil will become one of our most important markets within a not too distant future”, commented Peter Rothschild, President BioGaia.